1. Division of Epidemiology and Pharmacoepidemiology, Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan;
2. Department of Rheumatology, Ome Municipal General Hospital, Tokyo, Japan;
3. Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan;
4. Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical School, Saitama, Japan;
5. Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Tochigi, Japan;
6. Division of Hematology, Rheumatology and Respiratory Medicine Department of Internal Medicine Faculty of Medicine Kagawa University, Kagawa, Japan;
7. Department of Dermatology, St. Marianna University School of Medicine, Kanagawa, Japan;
8. Department of Otolaryngology-Head and Neck Surgery, Asahikawa Medical University, Hokkaido, Japan;
9. Department of Rheumatology, Shimane University Faculty of Medicine, Shimane, Japan;
10. Department of Nephrology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;
11. Department of Nephrology and Laboratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan;
12. Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan;
13. Department of General Medicine, Tokyo Kita Medical Center, Tokyo, Japan;
14. Department of Health Informatics, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan;
15. Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan;
16. Division of Nephrology and Rheumatology, First Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan